Page last updated: 2024-10-24

carbamazepine and Gastrointestinal Stromal Tumors

carbamazepine has been researched along with Gastrointestinal Stromal Tumors in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Gastrointestinal Stromal Tumors: All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).

Research Excerpts

ExcerptRelevanceReference
"Chronic oral anticancer therapies, are increasingly prescribed and present new challenges including the enhanced risk of overlooked drug-drug interactions (DDIs)."1.91The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure. ( Buonadonna, A; Canil, G; Cecchin, E; Dalle Fratte, C; Gagno, S; Guardascione, M; Orleni, M; Posocco, B; Roncato, R; Toffoli, G; Zanchetta, M, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gagno, S1
Buonadonna, A1
Dalle Fratte, C1
Guardascione, M1
Zanchetta, M1
Posocco, B1
Orleni, M1
Canil, G1
Roncato, R1
Cecchin, E1
Toffoli, G1

Other Studies

1 other study available for carbamazepine and Gastrointestinal Stromal Tumors

ArticleYear
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2023, Volume: 31, Issue:2

    Topics: Antineoplastic Agents; Carbamazepine; Chromatography, Liquid; Drug Interactions; Drug Monitoring; Ga

2023